Seegene’s unveiling of CURECA™, the world’s first fully unattended PCR automation system, represents a historic leap in molecular diagnostics. By automating every stage of the PCR testing process-from sample storage and pre-treatment to nucleic acid extraction, amplification, and result interpretation-CURECA™ eliminates the need for human intervention and enables true 24/7 continuous operation. This innovation directly addresses long-standing inefficiencies in molecular testing, including high labor demands, human error, and inconsistencies in sample handling. The system’s breakthrough lies in its ability to automate the most complex and error-prone pre-treatment stage across all major sample types, including viscous and particulate-rich specimens like stool-an area that has long resisted automation.
In tandem, STAgora™, Seegene’s AI-driven statistical analysis platform, complements this hardware innovation by transforming raw PCR data into actionable clinical insights. STAgora™ aggregates real-time diagnostic data from global healthcare institutions to provide dynamic epidemiological intelligence, including positivity trends, co-infection patterns, and hospital-level analytics. Clinicians can use the platform to contextualize patient results within local and regional patterns, thereby enabling faster and more precise treatment decisions. With over 40 tailored statistical tools, STAgora™ empowers healthcare providers to shift from reactive to predictive care, leveraging diagnostics not only for confirmation but for proactive disease monitoring and control.
Together, CURECA™ and STAgora™ signal a new era in laboratory medicine, where diagnostics are no longer constrained by manual processes or isolated data silos. These technologies align with the growing need for scalable, standardized, and data-enriched diagnostic solutions-especially in high-volume labs and during public health emergencies. As Seegene builds global partnerships and launches pilot programs, the potential for widespread adoption grows. Beyond PCR, the system’s modular design opens doors for future applications in clinical chemistry and immunoassays, paving the way for holistic automation across diagnostic disciplines. With this bold step, Seegene positions itself as a global catalyst for transformative change in the diagnostics ecosystem.
MedTech Spectrum's Summary
First-of-Its-Kind PCR Automation: Seegene’s CURECA™ is the world’s first system to fully automate the entire PCR testing workflow, significantly reducing human error, improving efficiency, and enabling true 24/7 diagnostics across diverse sample types.
AI-Powered Data Intelligence: The STAgora™ platform transforms real-time PCR data into actionable clinical and epidemiological insights, empowering faster, more personalized, and regionally informed healthcare decisions.
A New Diagnostic Paradigm: Together, CURECA™ and STAgora™ set a new global standard in laboratory automation and data integration, paving the way for scalable, predictive, and fully connected diagnostics across multiple disciplines.
